Beck R A, Munch-Petersen B, Dölker M, Cloos L, Tyrsted G, Eger K
Universität Leipzig, Institut für Pharmazie, Germany.
Pharm Acta Helv. 1996 Oct;71(4):279-91. doi: 10.1016/s0031-6865(96)00029-5.
Selected thymidine derivatives were synthesized with various spacers and fixed as model compounds at position N-3', C-5, C-3' and C-5', respectively, to simulate the preparation of an affinity gel matrix. Compounds 3, 6, 7 and 9 were evaluated for their effect on pure human cytosolic thymidine kinase (TK). All four compounds showed competitive inhibition with respect to thymidine, with Ki-values between 80 and 1000 microM. In the same positions as the model compounds were bound to the spacers thymidine derivatives were coupled with different Sepharose gel matrices. These affinity matrices were tested for isolation of thymidine kinase out of placental enzyme material. Except for one matrix, more than 98% of the applied activity was retained by the affinity matrices tested. The strongest binding to the enzyme resulted from a fixation at C-5' of the thymidine molecule to the gel matrix.
合成了带有各种间隔基的特定胸苷衍生物,并分别将其固定在N-3'、C-5、C-3'和C-5'位作为模型化合物,以模拟亲和凝胶基质的制备。对化合物3、6、7和9进行了评估,以研究它们对纯人胞质胸苷激酶(TK)的作用。所有这四种化合物对胸苷均表现出竞争性抑制作用,其抑制常数(Ki值)在80至1000微摩尔之间。在与模型化合物结合到间隔基相同的位置上,将胸苷衍生物与不同的琼脂糖凝胶基质偶联。测试了这些亲和基质从胎盘酶材料中分离胸苷激酶的能力。除一种基质外,所测试的亲和基质保留了超过98%的应用活性。胸苷分子在C-5'位固定到凝胶基质上导致与酶的结合力最强。